Friday 10 March 2023

FDA Approves Fast-Acting Nasal Spray for Migraines, Pfizer Says

Clinical trials showed the nasal spray provided migraine relief within 15-30 minutes of use, with the relief lasting up to 48 hours in many patients.



from WebMD Health https://ift.tt/OuV3zD9

0 comments:

Post a Comment